Clinical efficacy an d prognosis analysis of intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction

Li Shufang; Niu Fulai; Yang Ruixia; Yu Tiantian

您当前的位置：

首页 >

文章列表页 >

Clinical efficacy an d prognosis analysis of intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction

更新时间：2022-11-04

- Clinical efficacy an d prognosis analysis of intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
- Health Medicine Research and Practice Vol. 19, Issue 2, Pages: 23-27(2022)
- 作者机构：
  
  济源市人民医院神经内科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R743.33
- Published：2022，
扫描看全文
Li Shufang, Niu Fulai, Yang Ruixia, et al. Clinical efficacy an d prognosis analysis of intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction. [J]. Health Medicine Research and Practice 19(2):23-27(2022)
DOI：

Li Shufang, Niu Fulai, Yang Ruixia, et al. Clinical efficacy an d prognosis analysis of intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction. [J]. Health Medicine Research and Practice 19(2):23-27(2022) DOI：

摘要

目的探讨阿替普酶静脉溶栓治疗急性脑梗死（ACI）的效果及预后。方法回顾性分析2016年3月—2019年3月济源市某医院收治的107例ACI患者的临床资料

根据治疗方式分为研究组（n=57）和对照组（n=50）。对照组采用常规溶栓治疗

研究组采用阿替普酶静脉溶栓治疗

比较2组患者的临床疗效、早期溶栓后症状改善情况及不良反应发生情况

采用多元Logistic回归分析患者预后的影响因素。结果 2组患者治疗后1周及治疗后1个月时美国国立卫生研究院卒中量表（NIHSS）评分低于治疗前且研究组低于对照组

Barthel指数（BI）高于治疗前且研究组高于对照组

差异均有统计学意义（P

0.05）。研究组患者治疗总有效率为98.25%

高于对照组的82.00%

差异有统计学意义（χ

=6.490

P=0.011）。研究组患者不良反应发生率为3.51%

低于对照组的18.00%

差异有统计学意义（χ

=6.064

P=0.014）。预后良好与预后不良患者年龄、营养状况、治疗前NIHSS评分、溶栓治疗方式比较

差异有统计学意义（P

0.05）。多因素分析结果显示

营养状况不良、治疗前NIHSS评分≥16分、常规溶栓治疗是影响ACI患者预后的危险因素（P

0.05）。结论阿替普酶静脉溶栓治疗ACI患者临床疗效显著

且影响ACI患者预后的危险因素较多

应采用合理措施对合并危险因素的高危患者进行干预以改善预后。

Abstract

Objective To investigate the effect and prognosis of intravenous thrombolysis with alteplase for acute cerebral infarction（ACI）. Methods The clinical data of 107 patients with ACI admitted to a hospital in Jiyuan from March 2016 to March 2019 were retrospectively analyzed and divided into a study group（n=57） and a control group（n=50） according to the treatment method. The control group was treated with conventional thrombolysis and the study group was treated with intravenous thrombolysis with aprotinin

and the clinical efficacy

improvement of early thrombolytic symptoms and occurrence of adverse reactions in the 2 groups were compared

and the factors influencing the prognosis of patients were analyzed by multivariate logistic regression. Results The NIHSS scores were lower in the study group than in the control group at 1 week and 1 month after treatment

and the Barthel Index（BI） was higher in the study group than in the control group

and the differences were statistically significant（P<0.05）. The total effective rate of treatment for patients in the study group was 98.25%

which was higher than that of 82.00% in the control group

and the difference was statistically significant（χ~2=6.490

P=0.011）. The incidence of adverse reactions in patients in the study group was 3.51%

which was lower than that of 18.00% in the control group

and the difference was statistically significant（χ~2=6.064

P=0.014）. The differences were statistically significant（P<0.05） when comparing the age

nutritional status

pre-treatment NIHSS score

and thrombolytic treatment method in patients with good prognosis to those with poor prognosis. The results of multifactorial analysis showed that poor nutritional status

pretreatment NIHSS score ≥16

and conventional thrombolytic treatment were risk factors affecting the prognosis of patients with ACI（P<0.05）. Conclusion The clinical efficacy of intravenous thrombolysis with alteplase in ACI patients is significant

and there are many risk factors affecting the prognosis of ACI patients

and reasonable measures should be used to intervene in high-risk patients with combined risk factors to improve the prognosis.

关键词

阿替普酶静脉溶栓急性脑梗死临床疗效预后

Keywords

Intravenous thrombolysis with alteplaseAcute cerebral infarctionClinical efficacyPrognosis

references

查看原文

Views

123

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effectiveness of nursing points integrated release program in pre-hospital emergency care for patients with acute cerebral infarction

Ef fects of multi-post collaboration-based intensive blood glucose management in the postoperative glucose management of diabetic patients underwent CABG

Clinical efficacy analysis of Danshen Chuanxiongzin injection combined with edaravone in the treatment of acute cerebral infarction

Efficacy of tenofovir combined with ursodeoxycholic acid in outpatient treatment of chronic hepatitis B

Analysis of factors affecting serum 25-hydroxyvitamin D₃ levels in children with infectious diarrhea

Related Author

Yang Hua

Yang Ling

Wang Sujuan

Zhang Ziran

Li Shanshan

Liu Ben

Chen Xuejiao

Liu Qiuju

Related Institution

Department of Emergency Medicine, Anyang People’s Hospital

Department of Cardiac Surgery, The 7th People’s Hospital of Zhengzhou

Department of Neurology,Xiping People’s Hospital

Department of Infection, Jiaozuo Third People’s Hospital

Department of Pe diatrics, The First Affiliated Hospital of Nanyang Medical College

⁰